A study was carried out to investigate compatibility of amlodipine besylate and olmesartan medoxomil with a variety of pharmaceutical excipients. Both drugs are antihypertensive agents that can be administered alone, in monotherapy, or in pharmaceutical association. e studies were performed using binary and ternary mixtures, and samples were stored for 3 and 6 months at 40°C under 75% relative humidity and dry conditions. For this study, a method based on high-performance liquid chromatography (HPLC) was developed and validated for the simultaneous determination of amlodipine besylate and olmesartan medoxomil in samples from pharmaceutical preformulation studies using diode array detector (DAD) and charged aerosol detector (CAD). e runtime per sample was 10 min with retention time of 7.926 min and 4.408 min for amlodipine and olmesartan, respectively. e validation was performed according to ICH guidelines. e calibration curve presents linear dynamic range from 12 to 250 μg mL −1 for amlodipine and from 25 to 500 μg mL −1 for olmesartan with coe cient of determination (R 2 ≥ 0.9908) while repeatability and reproducibility (expressed as relative standard deviation) were lower than 1.0%. e excipients such as corn starch, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, talc, polyvinylpyrrolidone, lactose monohydrate, and polyethylene glycol showed potential incompatibilities after accelerated stability testing.
Introduction
Amlodipine besylate (AMLO), CAS 111470-99-6, 3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1, 4-dihydro-6-methyl-3,5-pyridinedicarboxylate benzenesulphonate, is a calcium channel blocker used in treatment of hypertension, angina pectoris, and other cardiovascular diseases. Figure 1(a) shows the chemical structure of amlodipine besylate [1] [2] [3] .
Olmesartan medoxomil (OLME), CAS 144689-63-4, 1H-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl) [1,1′-biphenyl] -4yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester, is a prodrug that is subjected to enzymatic hydrolysis, and its active product, olmesartan, is an angiotensin II receptor blocker (ARB) used in treatment and prophylaxis of hypertension. Figures 1(b) and 1(c) show the chemical structure of olmesartan medoxomil and of its active product, olmesartan [4] [5] [6] [7] .
At the treatment of hypertension, the monotherapy has adequate therapeutic response, but at least 70% of the patients require two or more medications for the adequate blood pressure control. For these cases, the pharmaceutical association is a proper administration of drugs [8] .
e United States Pharmacopeial Convention (USP) recommends for the determination of AMLO the liquid chromatography (LC) assay using a mobile phase containing methanol, acetonitrile, and bu er solution (trimethylamine and phosphoric acid, pH 3.0) at the proportion of 35 : 15 : 50. For the determination of OLME, the USP recommends the LC assay using a mobile phase containing bu er solution (phosphoric acid, pH 3.4) and acetonitrile at the proportion of 33 : 77 [9] .
e simultaneous determination of AMLO and OLME is already reported in the literature in human plasma [2, 10] , urine, [10] and dosage form [11] [12] [13] . However, to date, there are no reports on the use of charged aerosol detector (CAD) on determination of AMLO and/or OLME.
e CAD is a relatively recent technology, and its main characteristic is to be a universal detector for nonvolatile analytes. e response may vary according to the composition of the mobile phase, and there are some limitations about the mobile phase: these may not be saline and the solvent must be volatile. e CAD is a detector independent of the chemical structure, optical properties, and the ionization capacity of the analytes, producing a similar response for di erent compounds, which allows the quanti cation even when there is no standard availability, since the detector measures the amount of charge, which is proportional to the amount of analytes. At CAD, the HPLC eluent is nebulized by Venturi e ect produced by a carrier inert gas, usually nitrogen, transforming the eluent into small droplets. e small droplets are carried by the gas ow to a drying tube where the solvent is evaporated. e aerosol formed is charged with a secondary stream of nitrogen that has passed a high-voltage platinum wire, and the charged aerosol is measured by an electrometer [14] [15] [16] [17] [18] [19] [20] [21] .
e drug-excipient compatibility study is an important step in the development of pharmaceutical dosage forms.
e incompatibility of a drug with one or more excipients in a formulation can a ect the stability and/or bioavailability of the active product, thereby a ecting its safety and e cacy of the formulation. e drug-excipient incompatibility can be due to the covalent reaction between the drug and the excipient, and/or the excipient-promoted intrinsic degradation of the drug. is study also allows to know the type of packaging most suitable and to establish adequate conditions of storage [22] [23] [24] [25] .
e purpose of this work was to develop and validate a sensitive LC method with CAD for determination of AMLO and OLME, which could be applied to drug-excipient compatibility studies.
Experimental

Chemicals and Reagents.
Amlodipine besylate and olmesartan medoxomil were supplied by Aché (Guarulhos, Brazil). e pharmaceutical excipients, such as corn starch, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, titanium dioxide, polyvinyl alcohol, talc, polyvinylpyrrolidone (PVP), lactose monohydrate, and polyethylene glycol (PEG), generally used in the formulation with AMLO and OLME, were of USP grade. Acetonitrile of LC grade (J.T. Baker, USA) and extrapure ammonium acetate (Nuclear, Brazil) were used to prepare the mobile phase for LC analysis. For development and validation of HPLC-CAD method, amlodipine besylate pharmaceutical standard (SigmaAldrich, Saint Louis, USA) and olmesartan medoxomil European Pharmacopoeia Reference Standard (European Directorate for the Quality of Medicines & Healthcare, Strasbourg, France) were used. A Master System MS2000 water puri cation (Gehaka, Brazil) was used to obtain ultrapure water (resistivity of 18 MΩ cm −1 ).
Apparatus and Chromatographic
Conditions. For HPLC analysis, liquid chromatographic system UHPLC Ultimate 3000 ( ermo Scienti c Dionex, USA), consisting of an LPG-3400RS pump with integrated vacuum degasser, autosampler WPS-3000RS with 100 μL injector, TCC-3000RS column oven, DAD-3000RS diode array detector, and Dionex Corona ultra RS charged aerosol detector, was used. In brief, isocratic elution with the column Eclipse XDB-C18 (4.6 × 250 mm, 5 μm; Agilent, Saint Clair, USA) at room temperature (25°C) employing a mobile phase consisting of ammonium acetate (pH 6.8 at 0.5 mol L ) and acetonitrile (40 : 60, v/v) was carried out.
e injection volume was 10 µL, and the ow rate was 0.5 mL min . Mobile phase, standard solutions, and samples were ltered through nylon lter (0.45 µm; Sartorius, Göttingen, Germany) before injection into the chromatographic system. e software Chromeleon 6.8 ( ermo Scienti c Dionex, Waltham, USA) was used to record chromatograms, peak quanti cation, and integration.
is methodology was inspired by the methodology described by Qutab et al. [12] . e change in ow rate was performed to improve the chromatographic resolution and symmetry of the peaks, and the reduction of injection volume occurred due to the high concentrations of samples to be determined. e optimum conditions of CAD used the acquisition rate was 10 Hz to have a su cient number of data points, and the time constant lter, used to reduce the noise in chromatogram, was level 0. e optimization of CAD conditions was performed observing the resolution and symmetry of the peaks.
Validation of the Method.
Validation studies were performed according to ICH guidelines to characterize the proposed analytical method such as dynamic range, calibration curve, limit of detection (LOD), limit of quantitation (LOQ), accuracy, precision, and method robustness [26] .
e dynamic range was selected within 15.0-250.0 μg mL −1 for AMLO and 25.0-500.0 μg mL −1 for OLME. Linear and polynomial (order 2) calibration curves were obtained by plotting the peak area against the nominal concentration by least squares [22, 27] .
To determine LOD and LOQ, comparisons between measurements of reference standard solutions at low concentrations of analyst and blank samples were performed; the LOD and LOQ were de ned as signal-to-noise ratio of 3 : 1 and 10 : 1, respectively [26, 28] . e accuracy was determined by the recovery method. ree samples were analyzed before and after the addition of a known amount of each analyte standard solution. e precision indicates the ability of the methodology to provide reproducible results. e intraday precision was evaluated by replicates of three samples on one day, whereas the interday precision was determined over three consecutive days.
Speci city was determined by comparing any interfering peaks from the blank, pure excipients, and ternary mixtures at initial time injection and checking the peak purity by HPLC-DAD.
Small changes in chromatographic conditions such as mobile phase (proportion of acetonitrile in 60 ± 2%), column temperature (25 ± 5°C), and ow rate (0.5 ± 0.1 mL min −1 ) were done to evaluate the robustness of the proposed HPLC method.
Drug-Excipient Compatibility Studies.
e stability study was performed using AMLO and OLME alone, binary mixtures formed by AMLO and each selected pharmaceutical excipient at a 1 : 1 (m/m) ratio, binary mixtures formed by OLME and each selected pharmaceutical excipient at a 1 : 1 (m/m) ratio, ternary mixtures formed by AMLO, OLME, and each selected pharmaceutical excipient at a 1 : 4 : 5 (m/m/m) ratio, and a binary mixture formed by AMLO and OLME at a 1 : 4 (m/m) ratio. e mixtures were prepared using analytical balance (Shimadzu AUW220D) and submitted to a physical homogenization using a vortex for 5 min. Each mixture was quartered into ve portions.
e rst portion of samples was analyzed immediately. Two portions of samples were also stored for 3 and 6 months in a stability chamber at 40 ± 0.5°C using a saturated NaCl solution (average of 75 ± 1% RH) monitored by a temperature/humidity data logger. And, two portions of samples were also stored for 3 and 6 months in a stability chamber at 40 ± 0.5°C and dry conditions [22] .
Results and Discussion
Method Validation.
e chromatographic results were evaluated using DAD and CAD. At DAD, the optimum wavelengths selected were 239 nm and 250 nm for AMLO and OLME, respectively. e typical chromatograms of AMLO and OLME obtained by the HPLC-based method are presented in Figure 2 . e average retention times of OLME and AMLO were 4.336 and 7.854 min, respectively. In the AMLO chromatogram obtained by CAD, there are two peaks: the rst at 3.987 min, from besylate fraction, and the second peak at 7.926 min, from AMLO.
e OLME chromatogram registered by CAD present only one peak at 4.408 min. e delay observed at retention time registered by DAD and CAD occurs because of the additional distance that the ow must travel to reach this detector.
Calibration Curve.
e dynamic range and calibration curve were estimated by analyzing AMLO and OLME standards. e calibration curves of AMLO and OLME were built at the range from 15.0 to 250.0 μg mL −1 and from 25.0 to 500.0 μg mL −1 , respectively. e calibration curves were linear with DAD response. e coe cient of determination (R 2 ) was equal to or better than 0.995. e relative standard deviation values of the slope were equal to or better than 3%. For each point of calibration standards, the concentrations were recalculated from the equation of the linear regression curves. e calibration curves with CAD data were calculated with linear and polynomial ts (Table 1) . e polynomial t showed better coe cient of determination (R 2 > 0.999) than linear t (R 2 > 0.991). A linear response was not expected, since aerosol charging does not depend directly on the aerosol mass. Although it is known that Corona CAD response is nonlinear within the range of four orders of magnitude, we found that the signal is nearly linear in the examined ranges of analyzed compounds [14] [15] [16] [17] [18] [19] [20] [21] 29] .
Limit of Detection (LOD) and the Limit of Quantication (LOQ).
Determination of the signal-to-noise ratio (S/N) was performed by comparing the measured signals from samples of known low concentrations of the analyte with those of blank samples and establishing the minimum concentration at which the analyte can be reliably detected.
e LOD and LOQ for each calibration curve are presented in Table 1 .
Accuracy and Precision.
e accuracy of the recovery for AMLO and OLME was evaluated at three concentrations.
e mean recoveries for all samples from each run were in the range of 95.46-101.85% (Table 2 ). e precisions were calculated from ten consecutive injections of a sample, and the observed RSD values for AMLO and OLME were in the range of 0.42-0.57%. Intermediate precision was calculated from three days, with RSD values in the range of 0.67-0.96%.
Speci city.
e evaluation of the speci city of the method can be observed in Figures 2, 3 , and 4. Figure 2 shows that the drugs have well-resolved peaks. Observing Figure 3 , it can be stated that the excipients do not have peaks in the same retention time as drugs. Figure 4 shows that even in the presence of the excipients, the drug peaks showed no change in retention times and symmetry. e chromatograms show that no signi cant interfering peaks were observed at the retention times of analytes, and the peaks are well resolved, with resolution > 1.5. e peak purity match, calculated by software Chromeleon at ternary mixtures assays, was 99.93% with 0.06% RSD for AMLO and 98.76% with 0.08% RSD for OLME, based on DAD spectra of each run.
Robustness.
e robustness of the proposed HPLC method was evaluated by slight changes of the chromatographic parameters including the ow rate (±0.1 mL min −1 ), mobile phase (proportion of acetonitrile in 60 ± 2%), and column temperature (±5°C). Afterwards, the drug content and retention time were determined. e results summarized in Table 3 demonstrated that the proposed HPLC method was robust for its intended applications.
Drug-Excipient Compatibility Study.
e chromatograms of AMLO, OLME, and ternary mixtures with excipients at the initial time are presented in Figure 4 . In both HPLC detectors, DAD and CAD, none of excipients tested showed interference on the chromatographic pro le of the analytes, which makes the methodology adequate for the drug-excipient compatibility study.
After 3 and 6 months of incubation in a stability chamber at 40°C ± 1°C under dry and 75% ± 5% relative humidity conditions, the samples were analyzed to verify the content of AMLO and OLME. e samples were prepared so that the expected concentration of AMLO was 100 μg mL
and OLME was 400 μg mL −1 , so these values corresponded to 100% of AMLO and OLME. e reduction of 5% in these values is indicative of drug degradation, and consequently, chemical incompatibility between the drug and the excipient [22] . e results of drug-excipient compatibility studies are summarized in Tables 4 and 5 , obtained by chromatograms of binary mixtures [30] .
At 40°C ± 1°C under dry conditions, AMLO and OLME, after 3 and 6 months, did not present changes in concentration recovery in binary and ternary mixtures, indicating that in dry conditions, the AMLO and OLME are compatible with the excipients in the studies.
At 40°C ± 1°C under 75% ± 5% relative humidity, after 3 months, AMLO and OLME did not present changes in concentrations in binary and ternary mixtures. However, after 6 months, the binary mixtures of AMLO with corn starch and lactose monohydrate and of OLME with PVP and lactose monohydrate presented concentration reduction.
And, the ternary mixtures showed concentration reduction of AMLO and OLME in the presence of croscarmellose sodium, magnesium stearate, polyvinyl alcohol, talc, PVP, lactose monohydrate, and PEG. e ternary mixture Table 4 : Recovery of AMLO and OLME after 3 and 6 months at 40°C ± 1°C under dry condition in binary and ternary mixtures.
Excipient
Binary mixtures Ternary mixtures 3 months 6 months 3 months 6 months AMLO (%) OLME (%) AMLO (%) OLME (%) AMLO (%) OLME (%) AMLO (%) OLME (%) containing corn starch showed concentration reduction only for AMLO. Because of these reductions in concentration of drugs, these excipients are not indicated for preparation of formulations containing AMLO and OLME.
us, if any of these excipients that presented incompatibility are used in the formulation of AMLO and OLME, this should be kept away from humidity and at milder temperatures.
Conclusions
e HPLC method for simultaneous determination of AMLO and OLME was validated according to ICH guidelines. e Corona CAD detector was found to be a powerful tool and, because it is relatively recent, has few validated methodologies.
e DAD presents lower LOD and LOQ than CAD. However, both detectors present satisfactory accuracy, precision, speci city, and robustness. e principal advantage of CAD over DAD is the fact that it is a detector independent of the chemical structure and optical properties. CAD allows the quanti cation even when there is no standard availability because it produces similar response for di erent compounds, since the detector measures the amount of charge, which is proportional to the amount of analyte [14, 15] .
e drug-excipient compatibility study showed that at 40°C, under dry conditions, there is no incompatibility, indicating that the tested excipients can be used at formulations containing AMLO and OLME, provided they are stored away from humidity. At 40°C, under 75% of relative humidity, the excipients such as corn starch, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, talc, PVP, lactose monohydrate, and PEG showed chemical incompatibility with AMLO and OLME, and because of it these excipients are not indicated for the preparation of formulations of AMLO and OLME. us, if they are used, the formulation should be kept away from humidity and at milder temperatures.
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